Amanda Prestigiacomo

Now, specifically, this order is going to allow Americans to buy drugs directly from manufacturers, cutting out those middlemen. These so-called middlemen are PBMs or pharmacy benefit managers. They work with insurance providers to negotiate prices with drug companies in exchange for including those drugs in their coverage.

Now, critics have said that PBMs are not transparent and they don't actually have incentive to lower prices for Americans. The order also sets a 30-day deadline for HHS to work with these drug makers to lower prescription drug costs. If a deal is not reached in time, a new rule is going to kick in that will effectively make these drugs the same price as other nations are paying for them.

Now, critics have said that PBMs are not transparent and they don't actually have incentive to lower prices for Americans. The order also sets a 30-day deadline for HHS to work with these drug makers to lower prescription drug costs. If a deal is not reached in time, a new rule is going to kick in that will effectively make these drugs the same price as other nations are paying for them.

Trump was asked on Monday if this order now means that America is setting price controls. Here's how he responded.

Trump was asked on Monday if this order now means that America is setting price controls. Here's how he responded.

Dr. Marty McCary, who's now leading the FDA, he spoke at the press conference too, and he was very passionate about this order.

Dr. Marty McCary, who's now leading the FDA, he spoke at the press conference too, and he was very passionate about this order.

HHS Secretary Robert F. Kennedy Jr., also at the presser, he targeted the EU as well. He said that if they were to chip in for R&D and raise their prices by just 20 percent, that would dramatically reduce prices for Americans.

HHS Secretary Robert F. Kennedy Jr., also at the presser, he targeted the EU as well. He said that if they were to chip in for R&D and raise their prices by just 20 percent, that would dramatically reduce prices for Americans.

Yeah, we're not hearing a lot from Democrats at the moment. We did get a response from Senator Bernie Sanders, who talks a lot about these drugs. He said he did agree with Trump that prices are too high, but he didn't back this order. He argued that it's going to be blocked by the courts. As for the right, there's a little bit of skepticism about how this is all going to be implemented.

Yeah, we're not hearing a lot from Democrats at the moment. We did get a response from Senator Bernie Sanders, who talks a lot about these drugs. He said he did agree with Trump that prices are too high, but he didn't back this order. He argued that it's going to be blocked by the courts. As for the right, there's a little bit of skepticism about how this is all going to be implemented.

But overall, there is a lot of support, especially since this is all being framed by Trump as an America first policy. Well, a lot of cautious optimism, at least.

But overall, there is a lot of support, especially since this is all being framed by Trump as an America first policy. Well, a lot of cautious optimism, at least.

Mr. President, why don't you say to people who view that luxury jet as a personal gift to you, why not leave it behind?

Mr. President, why don't you say to people who view that luxury jet as a personal gift to you, why not leave it behind?

Yeah, it definitely was sudden. Trump pulled Dr. Jeanette Neshua, his former nominee, just one day before she was scheduled to appear for confirmation hearings. Neshawat was criticized by the Maha crowd and conservatives for some of her advocacy during COVID, specifically on vaccines and masks.

Yeah, it definitely was sudden. Trump pulled Dr. Jeanette Neshua, his former nominee, just one day before she was scheduled to appear for confirmation hearings. Neshawat was criticized by the Maha crowd and conservatives for some of her advocacy during COVID, specifically on vaccines and masks.

She also didn't seem to align with RFK in the Maha space, so obviously some conservatives were just not thrilled about that nomination. Means, on the other hand, she seems like a much better fit. She advised RFK during his 2024 presidential run, and she reportedly helped broker Kennedy's endorsement of Trump. That was a huge moment for the Trump campaign.

She also didn't seem to align with RFK in the Maha space, so obviously some conservatives were just not thrilled about that nomination. Means, on the other hand, she seems like a much better fit. She advised RFK during his 2024 presidential run, and she reportedly helped broker Kennedy's endorsement of Trump. That was a huge moment for the Trump campaign.

Yeah, Means is a Stanford University-trained surgeon, and she's the author of Good Energy. That book discusses metabolic dysfunction and chronic illness. When she was at Stanford, she became disillusioned with how she saw medicine being practiced, especially when it came to chronic illness.